dr. germain on scientific rationale behind bortezomib/fulvestrant for hr breast cancer
Published 9 years ago • 237 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
2:30
germain, adelson: fulvestrant for hr breast cancer
-
6:04
faslodex (fulvestrant) for hr breast cancer: comprehensive treatment guide
-
1:26
dr. adelson on bortezomib plus fulvestrant for hr breast cancer
-
7:26
s1222 hr , stage iv breast cancer: fulvestrant w/wo everolimus /- anastrozole
-
6:20
fulvestrant and palbociclib as first-line treatment for hr /her2- breast cancer
-
1:30
girlfriend is terrified of needles!
-
11:41
found in translation: the tale of the cancer drug bortezomib (velcade)
-
4:14
bone only metastatic breast cancer, what is the best approach?
-
1:29
capitello-292: capivasertib, palbociclib, and fulvestrant for hr endocrine-resistant breast cancer
-
7:25
fulvestrant in breast cancer
-
1:07
estrogen receptor antagonists - fulvestrant
-
5:52
matador: immune gene profiles in tailoring breast cancer treatment
-
4:15
lasofoxifene vs fulvestrant for hr-positive breast cancer
-
6:37
the estrogen-receptor antagonist fulvestrant in breast cancer
-
0:55
fulvestrant plus palbociclib in breast cancer
-
3:25
overall survival with fulvestrant plus anastrozole in metastatic breast cancer. - pubmed
-
4:26
dr. mark gilbert discusses frontline bevacizumab in glioblastoma
-
5:49
perspectives on the olympia study of adjuvant olaparib in early breast cancer | nadine tung
-
9:12
fulvestrant improves survival over anastrozole for patients with advanced breast cancer
-
1:26
biosimilars: the future of treating breast cancer
-
0:45
an overview of novel glioblastoma biomarkers
-
6:25
combination of anastrozole and fulvestrant in metastatic breast cancer